No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Biocompatible Materials
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / surgery
-
Carmustine / administration & dosage
-
Carmustine / adverse effects
-
Carmustine / therapeutic use
-
Carmustine / toxicity
-
Chemotherapy, Adjuvant
-
Clinical Trials, Phase II as Topic
-
Clinical Trials, Phase III as Topic
-
Combined Modality Therapy
-
Decanoic Acids
-
Delayed-Action Preparations
-
Double-Blind Method
-
Drug Carriers
-
Drug Implants
-
Drug Screening Assays, Antitumor
-
Glioblastoma / drug therapy
-
Glioblastoma / mortality
-
Glioblastoma / surgery
-
Glioma / drug therapy*
-
Glioma / surgery
-
Humans
-
Neoplasm Recurrence, Local / drug therapy
-
Polyesters*
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Rats
-
Salvage Therapy
-
Survival Analysis
Substances
-
Antineoplastic Agents
-
Biocompatible Materials
-
Decanoic Acids
-
Delayed-Action Preparations
-
Drug Carriers
-
Drug Implants
-
Polyesters
-
decanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymer
-
Carmustine